Australia markets closed

Haleon plc (HLN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
328.22-2.78 (-0.84%)
As of 12:15PM BST. Market open.
Full screen
Previous close331.00
Open330.40
Bid328.10 x N/A
Ask328.30 x N/A
Day's range326.10 - 330.42
52-week range306.80 - 350.50
Volume3,345,819
Avg. volume26,086,705
Market cap29.974B
Beta (5Y monthly)N/A
PE ratio (TTM)29.84
EPS (TTM)0.11
Earnings date01 Aug 2024 - 15 Aug 2024
Forward dividend & yield0.06 (1.77%)
Ex-dividend date14 Mar 2024
1y target est363.53
  • Reuters

    UPDATE 2-Sensodyne-maker Haleon posts tepid sales as demand for some products cool off

    Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates on Wednesday, as volumes declined due to retailer destocking in U.S. and cooling demand for some of its medicines after a surge last year. The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil's sales in Canada, following a surge in demand last year. Demand for medicines such as Contac and Fenbid, which benefited from pent-up demand in China last year after lockdown restrictions were lifted, have also cooled, impacting Haleon's quarterly sales growth.

  • Reuters

    Sensodyne-maker Haleon posts tepid sales as demand for some products cool off

    The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil's sales in Canada, following a surge in demand last year. Demand for medicines such as Contac and Fenbid, which benefited from pent-up demand in China last year after lockdown restrictions were lifted, have also cooled, impacting Haleon's quarterly sales growth. On a reported basis, revenue was down 2.2% on last year.

  • PA Media: Money

    Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

    The consumer healthcare group is aiming to close the site on a phased basis over the next two years.